Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ludwig EnterprisesLUDG EV-to-EBIT is -15.22 as of Aug. 02, 2026. The stock has 4 warning signs investors should review. Among 470 Medical Devices & Instruments companies, Ludwig Enterprises ranks worse than 212765.74% on this metric.
Ludwig Enterprises (OTCPK:LUDG) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Ludwig Enterprises's Enterprise Value for the quarter that ended in Mar. 2026 was $10.19 Mil.
Ludwig Enterprises's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.37 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ludwig Enterprises EV-to-EBIT Related Terms
Ludwig Enterprises EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Ludwig Enterprises's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Ludwig Enterprises's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ludwig Enterprises EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ludwig Enterprises's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Ludwig Enterprises's EV-to-EBIT falls into.
Ludwig Enterprises's current Enterprise Value is $5.65 Mil.
Ludwig Enterprises's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.37 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ludwig Enterprises (LUDG) has a EV-to-EBIT of -15.22 as of Aug. 02, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ludwig Enterprises and its competitors. According to the industry distribution chart, Ludwig Enterprises ranks #999999 out of 470 companies in the Medical Devices & Instruments industry.
Is Ludwig Enterprises' EV-to-EBIT too high?
Ludwig Enterprises' current EV-to-EBIT is -15.22. Based on the distribution chart, Ludwig Enterprises ranks #999999 out of 470 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Ludwig Enterprises' EV-to-EBIT compare to TNON and POAS?
According to the Medical Devices & Instruments industry distribution chart, Ludwig Enterprises ranks #999999 out of 470 companies for EV-to-EBIT. This places Ludwig Enterprises in the lower half of its industry. The industry median EV-to-EBIT is 18.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.85, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ludwig Enterprises and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ludwig Enterprises's current EV-to-EBIT is -15.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ludwig Enterprises stock overvalued right now?
Ludwig Enterprises (LUDG) has a current EV-to-EBIT of -15.22. The current EV-to-EBIT is -15.22. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Ludwig Enterprises (LUDG), the current EV-to-EBIT is -15.22 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ludwig Enterprises Inc is an early-stage genomic technology company focused on developing screening tests for inflammation-related chronic diseases, including cancers. Its platform integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits designed to provide a differentiated and patient-friendly approach to cancer screening. The company's business model combines a business-to-business-to-consumer (B2B2C) approach with partnerships through CLIA-certified laboratories. It is focused on offering home collection kits directly to patients, supported by certified genetic counselors, while also enabling independent laboratories to provide the Revealia Breast test (Ludwig's key product candidate) as a Laboratory Developed Test (LDT).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LUDG has been successfully added to your 
